PANOBEST (#470)
Laufzeit: 01.01.2013 - 31.12.2019
imported
Kurzfassung
Phase I/II study with oral Panobinostat maintenance therapy following allogeneic stem cell transplantation in patients with high risk MDS or AML (PANOBEST)